Human papillomavirus vaccine and behavioural disinhibition
نویسندگان
چکیده
منابع مشابه
Human papillomavirus vaccine and pregnancy.
UNLABELLED QUESTION A: patient of mine who recently learned she was 6 weeks pregnant had received the recombinant human papillomavirus (HPV) quadrivalent vaccine at 4 weeks of gestation. She is quite worried about how this will affect her baby. What is known about the safety of the HPV vaccine during pregnancy? ANSWER The HPV vaccine is generally not recommended for use in pregnant women. How...
متن کاملQuadrivalent human papillomavirus vaccine.
The lifetime risk of human papillomavirus (HPV) infection exceeds 50%. HPV infection causes >550,000 cases of cervical and anogenital cancer worldwide annually. Infection also causes precancerous lesions and genital warts. HPV types 16 and 18 cause approximately 70% of HPV-related cancers, and HPV types 6 and 11 cause approximately 90% of cases of genital warts. A quadrivalent vaccine for HPV t...
متن کاملTaking stock and looking ahead: Behavioural science lessons for implementing the nonavalent human papillomavirus vaccine
The development and licensing of a nonavalent human papillomavirus (HPV) vaccine has the potential to reduce morbidity and mortality from HPV-related cancers beyond that of first generation HPV vaccines. However, this benefit can only be realised if the offer of vaccination is accepted. Uptake of first generation HPV vaccines is not complete and shows huge global variation. In addition to pract...
متن کاملHuman papillomavirus vaccine for children and adolescents.
The purpose of the present statement is to review the Canadian Paediatric Society (CPS) recommendations on the use of HPV vaccine for children and youth in Canada. The epidemiology of HPV-6, -11, -16 and -18 infection and its associated diseases in Canada, as well as information on the currently approved vaccine is summarized. For an extensive review of HPV vaccine in Canada, readers are referr...
متن کاملCervical cancer and the human papillomavirus vaccine.
Background As a former sufferer from cervical cancer, I obviously gave a huge whoop of joy at the recent announcement about the human papillomavirus (HPV) vaccine. At last a simple, effective weapon to use against the disease. What’s not to like? But to be frank, I was sure I’d be a lone voice, at least in the wilderness of the lay domain. In an age when the fpa’s (Family Planning Association) ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Sexually Transmitted Infections
سال: 2011
ISSN: 1368-4973
DOI: 10.1136/sti.2010.048017